Showing results (321-330 of 380) with videos related to

Sort By:
Pageof 38
JAMA Oncology|September 23, 2018
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysisDaniel Y Wang, Joe-Elie Salem, Justine V Cohen, et al.
Cancers|June 2, 2021
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma PatientsGeorg Lodde, Andrea Forschner, Jessica Hassel, et al.
The British Journal of Dermatology|February 20, 2026
Melanoma of unknown primary shows oncogenic pattern and clinical course of sun-exposed melanomaGeorg Lodde, Jonida Dollani, Wolfgang Galetzka, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 15, 2017
SF3B1 and BAP1 mutations in blue nevus-like melanomaKlaus G Griewank, Hansgeorg Müller, Louise A Jackett, et al.
Journal for Immunotherapy of Cancer|January 31, 2024
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case seriesCatriona Harvey, Kazi J Nahar, Janet McKeown, et al.
International Journal of Cancer|July 8, 2024
Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADORegSebastian A Wohlfeil, Leonie Kranzmann, Christel Weiß, et al.
Nature Medicine|July 13, 2026
An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trialMatteo S Carlino, Ellen Kapiteijn, Sophie Piperno-Neumann, et al.
The New England Journal of Medicine|June 8, 2010
Improved survival with ipilimumab in patients with metastatic melanomaF Stephen Hodi, Steven J O'Day, David F McDermott, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2025
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanomaDirk Tomsitz, Elisabeth Livingstone, Carmen Loquai, et al.
Frontiers in Oncology|October 8, 2021
Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic MelanomaJan-Malte Placke, Camille Soun, Jenny Bottek, et al.
Pageof 38